Arax Advisory Partners’s Aclaris Therapeutics ACRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,632	Closed	-$1.88K	–	2417
2024 Q3	$1.88K	Hold	1,632	–	–	﹤0.01%	2087
2024 Q2	$1.8K	Buy	+1,632	New	+$1.8K	﹤0.01%	2003